Skip to content
← Full study record

NCT02186834 · MORE INFO

Limitations, agreements, and source contact

Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma · Source last updated 2023-01-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rachid.baz@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-8212
title
Dr. Rachid Baz
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rachid.baz@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-8212
title
Dr. Rachid Baz

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice